Dear Colleagues: Welcome to the March issue of Psychiatry 2010. In this month’s “Trend Watch,” the authors explore the penetration of generic atypical antipsychotics in the United States market before
by Susan Lenderts, BA; Amir H. Kalali, MD; and Peter Buckley, MD Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by Richard D. Sanders, MD, and Paulette Marie Gillig, MD, PhD Dr. Sanders is Associate Professor, Departments of Psychiatry and Neurology, Boonshoft School of Medicine, Wright State University, and Ohio
by Nuno Borja-Santos, MD, MSc; Bruno Trancas, MD; Pilar Santos Pinto, MD; Bárbara Lopes, MD; António Gamito, MD; Sandra Almeida, MD; Berta Ferreira, MD; Antonio Luengo, MD; Carlos Vieira, MD;